ArticleVaccines2022

Sinopharm's BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2.

Ahmed Samir Abdelhafiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.